Abstract
Introduction and purposeThe diagnosis of OSA in children is based on clinical symptoms and polysomnography (Apnea-Hypopnea Index ≥1 or hypoventilation). The ICSD-3 (International Classification of Sleep Disorders - Third Edition) guidelines are also utilized. Diagnostics are supported by pulse oximetry, lateral nasopharyngeal X-ray, cephalometry, fiberoptic endoscopy, and magnetic resonance imaging of the upper respiratory tract. OSA is associated with serious complications, including behavioral disorders, cardiovascular complications, metabolic disorders, and growth disturbances. Children with OSA also experience learning difficulties and lower school performance. Treatment includes adenotonsillectomy, CPAP/BiPAP therapy, surgical procedures, weight reduction, and pharmacotherapy. The effectiveness of treatment may be limited, particularly in obese children. Post-treatment monitoring of patients is necessary due to the risk of residual symptoms. Material and methodsThe literature available in Pubmed and Google Scholar databases was conducted using the key words. ResultsData indicate that OSA occurs in approx. 5% of children, especially during the preschool years and adolescence. Symptoms include loud snoring, respiratory pauses, behavioral disorders, school difficulties, and daytime sleepiness. Polysomnography remains the cornerstone of diagnosis, supported by the PSQ and modified STOP-BANG questionnaires. Untreated OSA leads to metabolic, cardiovascular, and neurobehavioral complications. Treatment includes adenotonsillectomy, PAP therapy, weight reduction, pharmacotherapy, and orthodontic management. Conclusions Obstructive sleep apnea in children is a disorder with significant health consequences, requiring prompt diagnosis and tailored treatment. Adenotonsillectomy is the primary treatment method, with additional therapies applied to patients with persistent symptoms or contraindications to surgery.